Reports for DABIGATRAN ETEXILATE

Ingredient

DABIGATRAN ETEXILATE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DABIGATRAN 150MG CAPSULE Resolved 2023-02-23 2023-03-23 185492
APO-DABIGATRAN 110MG CAPSULE Resolved 2024-12-05 2025-01-24 244888
APO-DABIGATRAN 110MG CAPSULE Actual shortage 2025-04-10 2025-05-01 254858
APO-DABIGATRAN 150MG CAPSULE Resolved 2020-04-13 2021-01-26 111898
APO-DABIGATRAN 150MG CAPSULE Resolved 2020-08-19 2021-01-26 122473
APO-DABIGATRAN 150MG CAPSULE Resolved 2021-07-09 2022-10-07 142272
APO-DABIGATRAN 150MG CAPSULE Resolved 2021-09-03 2023-09-15 145144
APO-DABIGATRAN 150MG CAPSULE Resolved 2024-06-14 2024-09-20 230558
APO-DABIGATRAN 150MG CAPSULE Actual shortage 2024-10-24 2024-10-24 241059
APO-DABIGATRAN 150MG CAPSULE Resolved 2024-07-12 2024-07-19 232842

Showing 1 to 10 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PRADAXA 110MG CAPSULE Discontinued 2017-12-21 2017-12-21 34114
PRADAXA 75MG CAPSULE To be discontinued 2025-04-17 2025-04-17 255171
PRADAXA 150MG CAPSULE Discontinued 2017-10-19 2017-10-19 26385

Showing 1 to 3 of 3